Excessive anticoagulation with warfarin or phenprocoumon may have multiple causes

被引:0
|
作者
Meegaard, Peter M.
Holck, Line H. V.
Pottegard, Anton [1 ]
Madsen, Hanne [2 ]
Hallas, Jesper
机构
[1] Univ So Denmark, Res Unit Clin Pharmacol, Inst Publ Hlth, DK-5000 Odense C, Denmark
[2] Odense Univ Hosp, Emergency Ward, Odense, Denmark
来源
DANISH MEDICAL JOURNAL | 2012年 / 59卷 / 02期
关键词
THERAPY; RISK;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
INTRODUCTION: Excessive anticoagulation with vitamin K antagonists is a serious condition with a substantial risk of an adverse outcome. We thus found it of interest to review a large case series to characterize the underlying causes of excessive anticoagulation. MATERIAL AND METHODS: Patients were identified both retrospectively and prospectively. The inclusion criteria were an international normalized ratio (INR) > 6.5 or INR > 3.5 and significant bleeding. Patient charts were reviewed for a predefined set of possible causes: Drug-drug interactions, alcohol abuse, disease, start-up or recent change in dosage and dosage errors. RESULTS: In 86 of 107 admissions one or more causal event were identified. The two most common causes of excessive anticoagulation were disease and drug-drug interactions. The two most common drug-drug interactions were with paracetamol and tramadol. In 44 admissions, a single cause was identified; in 42, two or more causes were identified. CONCLUSION: Although it is difficult to identify single initiatives that may reduce the number of admissions due to excessive anticoagulation, interesting areas include a stronger focus on frequent INR control during the various states of disease and heightened attention to drug-drug interactions.
引用
收藏
页数:5
相关论文
共 50 条
  • [41] Medicinal plants may have multiple benefits
    Senior, K
    FRONTIERS IN ECOLOGY AND THE ENVIRONMENT, 2005, 3 (10) : 522 - 522
  • [42] Adding IV UFH to standard enoxaparin causes excessive anticoagulation, not detected by ACT: results of the STACKENOX study
    Drouet, O.
    Sollier, C. Bal Dit
    Martin, J. L.
    EUROPEAN HEART JOURNAL, 2008, 29 : 327 - 327
  • [43] An excessive risk of suicide may no longer be a reality for multiple sclerosis patients
    Kalson-Ray, Shoshannah
    Edan, Gilles
    Leray, Emmanuelle
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 (06) : 864 - 871
  • [44] Risk Factors for Excessive Anticoagulation Among Hospitalized Adults Receiving Warfarin Therapy Using a Pharmacist-Managed Dosing Protocol
    Berg, Tamara M.
    O'Meara, John G.
    Ou, Narith N.
    Daniels, Paul R.
    Moriarty, James P.
    Bergstrahl, Eric J.
    Dierkhising, Ross A.
    Manning, Dennis M.
    PHARMACOTHERAPY, 2013, 33 (11): : 1165 - 1174
  • [45] REVERSAL OF EXCESSIVE EFFECT OF REGULAR ANTICOAGULATION - LOW ORAL DOSE OF PHYTONADIONE (VITAMIN-K1) COMPARED WITH WARFARIN DISCONTINUATION
    PENGO, V
    BANZATO, A
    GARELLI, E
    ZASSO, A
    BIASIOLO, A
    BLOOD COAGULATION & FIBRINOLYSIS, 1993, 4 (05) : 739 - 741
  • [46] Reversal of warfarin-induced excessive anticoagulation with recombinant human factor VIIa concentrate (vol 137, pg 884, 2002)
    Deveras, RA
    Kessler, CM
    ANNALS OF INTERNAL MEDICINE, 2003, 138 (08) : 692 - 692
  • [47] Cavitating lung disease spondylitis in ankylosing may have other causes
    Nour, EM
    Taylor, KJ
    HOSPITAL MEDICINE, 2005, 66 (03): : 174 - 175
  • [48] THE METHOD FOR REVERSING ANTICOAGULATION AFFECTS TREATMENT COSTS AND MAY DECREASE MORTALITY AMONG HIP FRACTURE PATIENTS USING WARFARIN
    Agthe, N.
    Purmonen, T.
    Kokki, H.
    VALUE IN HEALTH, 2012, 15 (07) : A444 - A444
  • [50] Safety and effectiveness of low-dose, oral vitamin K1 administration in asymptomatic out-patients on warfarin or acenocoumarol with excessive anticoagulation
    Poli, D
    Antonucci, E
    Lombardi, A
    Gensini, GF
    Abbate, R
    Prisco, D
    HAEMATOLOGICA, 2003, 88 (02) : 237 - 238